Needham reiterates Medtronic stock rating on strong product cycle
Covered in this story
What has happened since
- Medtronic is up 2.8% since this was published, 49 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Needham’s $114 target on $MDT is on the record and being tracked to Sep 2027 (12-month default), scored on the close that day.
Needham’s track record →Analyst targets on Medtronic
- Mizuho: $92.2 → $115 by Sep 2027 · Outperform via Investing.com
- Stifel: $92.2 → $95 by Sep 2027 · Hold via Investing.com
- BTIG: $92 → $100 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MDT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Medtronic →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.